Albert Einstein Invented A Kitchen Appliance. Here's Why It No Longer Exists
In 1926, they created a unique pump system meant to replace the faulty valves responsible for refrigerators' poisonous gas leaks. Instead of relying on moving parts that were prone to malfunction, Einstein and Szilard's pump compressed refrigerant gases using an electromagnetic field. Additionally, it didn't require electricity to function — only a heat source. The pair had a U.S. patent pending by 1927.
The following decade, however, was shaped by significant turmoil. Economic disaster rocked the world, and the rise of fascism threatened the Jewish inventors' very lives. But it wasn't just world-moving forces of history that derailed the so-called Einstein fridge. Market forces were also at play: Someone else invented something better.
Read more: 14 Condiments That Don't Need To Be Refrigerated
Depression, Prejudice, And Competition
Albert Einstein and Leo Szilard successfully sold their pending patent to the Swedish company Electrolux in 1927, but two years later the Great Depression crushed economies all over the world. With businesses, governments, and consumers all feeling the pressure, the pair's pump design didn't see much enthusiasm.
The early 1930s were especially hard on the inventors' home country of Germany, which already faced significant economic difficulty throughout the 1920s. The Great Depression helped accelerate the rise of the Nazis who, driven by a violent hatred of Judaism, scapegoated Jewish people for the country's woes. Rising antisemitic violence and discrimination made Germany unsafe for men like Einstein and Szilard, both of whom fled continental Europe by 1933.
Technology, however, had already advanced beyond their pump design. The American company General Motors invested in Thomas Midgely, who in 1928 invented Freon, a brand name for several chlorofluorocarbons (CFCs) which were a safer alternative to poisonous and explosive gases. They were also more efficient than the electromagnetic pump. By the time Einstein moved to America in 1933 and Szilard followed five years later, Freon was already making refrigerators a standard kitchen appliance as the U.S. economy slowly recovered.
What Happened To The Einstein Refrigerator?
Their refrigeration dreams dashed, Albert Einstein and Leo Szilard moved on to other projects, including the frontiers of nuclear energy. This resulted in their 1939 letter to President Franklin D. Roosevelt, warning him that Nazi Germany was likely to invent a nuclear weapon. Roosevelt took action, and what historians know as the Einstein-Szilard letter led to the Manhattan Project, the atomic bombing of Japan, and the post-war age of nuclear weapons.
In the world of refrigeration, the popular Freon formula known as R22 eventually became known as a major culprit of ozone layer depletion. Its gradual phase-out in favor of less harmful gases, including some that still go by the brand name Freon, is nearly complete.
The decline of the original Freon, however, did not mean the rise of the Einstein fridge. Its electricity-free design briefly showed promise for delivering refrigeration to areas without reliable power, but this revival has not yet come to fruition. The Einstein refrigerator mostly remains a historical footnote, like the lifelong digestive issues that briefly made Einstein a vegetarian before his death.
Hungry for more? Sign up for the free Daily Meal newsletter for delicious recipes, cooking tips, kitchen hacks, and more, delivered straight to your inbox.
Read the original article on The Daily Meal.
Solve the daily Crossword
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Scientists make key breakthrough that could solve major issue with EV batteries: 'The idea is to keep it simple'
Czech researchers have developed a new method for recycling rare earth minerals from electric vehicle batteries using just water and basic laboratory conditions, according to a recent report from Radio Prague International. The Institute of Organic Chemistry and Biochemistry focused its research on neodymium magnets, the strongest permanent magnets known to man. These powerful components drive EVs, smartphones, and wind turbines — but their production creates massive environmental challenges. Traditional mining and refining processes require hundreds of reactors, generate radioactive waste, and produce enormous amounts of acids and toxic byproducts. "The idea is to keep it simple, something that doesn't require extremely difficult conditions that would be hard to reproduce on an industrial scale," IOCB researcher Kelsea Jones explained, per Radio Prague International. The team's method uses water as a solvent and operates at room temperature, eliminating the need for harsh chemicals or extreme conditions. The process employs chelating agents, or organic molecules that bond with metal ions. Scientists add these agents to dissolved magnets, creating compounds with individual rare earth elements that can then be filtered by weight. The team processed magnets through several separation cycles and obtained neodymium with 99.7% purity, more than enough to produce new magnets. Reusing battery materials will reduce the risk of toxins leaching into soil and groundwater, and it will decrease resource depletion — a problem that often creates unsafe mining operations. EVs already help to improve air quality in our cities and reduce pollution compared to gas-powered cars, and more accessible battery recycling could help to accelerate EV adoption by making them more cost-effective. The Czech researchers have secured patents for their EV battery recycling method and are seeking commercial partners to bring this technology to market. Their breakthrough is a great example of the innovation needed to build a cleaner, more sustainable future — one that benefits both people and the planet. For those looking to make their next car an EV, this new recycling technology could also mean that even more affordable options are ahead. Should America invest more in EV battery tech? Absolutely No way Only if it brings down prices Only if it helps us compete with China Click your choice to see results and speak your mind. Join our free newsletter for weekly updates on the latest innovations improving our lives and shaping our future, and don't miss this cool list of easy ways to help yourself while helping the planet.
Yahoo
4 hours ago
- Yahoo
AI designs antibiotics to fight drug-resistant superbugs
An artificial intelligence model designed new antibiotics to fight gonorrhea and mRSA superbugs. The overuse of antibiotics can create resistance, when the drugs kill off all but those bacteria most capable of surviving the treatment. It has led to the rise of some bugs that are all but impossible to treat with existing antibiotics, raising fears that modern medicine and surgery — reliant on antibiotics — could collapse, given that few new antibiotics are produced. The new drugs were designed atom-by-atom using AI, and while they are a long way from the clinic, researchers hoped they could create a new pipeline for drugs. AI is rapidly transforming drug development and biology, allowing scientists to better predict how molecules behave in the body. Solve the daily Crossword


CNET
7 hours ago
- CNET
Generative AI Gave MIT Scientists a New Tool to Fight Antibiotic-Resistant Bacteria
Antibiotic-resistant bacteria are dangerous because they already "know" what most antibiotics look like. Scientists at MIT have found a way to create something new: using generative AI to design two antibiotic compounds from scratch that can kill drug-resistant gonorrhea and MRSA in lab dishes and mice. Antibiotic resistance is one of the world's biggest public health threats yet new antibiotics have been scarce for decades. Traditional drug discovery methods rely on screening known chemical libraries -- a slow process with a limited pool of existing molecules to test. In contrast, MIT's AI system generated more than 36 million theoretical compounds, many with chemical structures never seen before, and zeroed in on two standouts. Both are unlike any antibiotic currently in use, offering a glimpse at how AI can move beyond speeding up research to imagine medicines that might have been impossible to find otherwise. "We wanted to get rid of anything that would look like an existing antibiotic, to help address the antimicrobial resistance crisis in a fundamentally different way," said Aarti Krishnan, MIT postdoc and one of the study's lead authors. "By venturing into underexplored areas of chemical space, our goal was to uncover novel mechanisms of action." Read also: Do You Really Learn When You Use AI? What MIT Researchers Found How the science was pulled off The MIT team bypassed the limitations of screening existing chemical libraries by asking AI to invent molecules from scratch, generating more than 36 million theoretical compounds, which were then narrowed down to a few to be tested against drug-resistant superbugs. This involved two AI-driven strategies: Fragment-based design: The AI began with a chemical fragment (labeled F1) that showed promise against gonorrhea. It produced millions of derivatives, ultimately refining a shortlist of about 1,000 candidates. Of the 80 chosen by researchers, NG1 emerged as a standout compound that successfully treated drug-resistant gonorrhea in cell cultures and a mouse. Unconstrained generation: The team let the AI roam freely, designing molecules on its own, aiming at MRSA. This produced more than 29 million candidates, which were filtered down to 90 compounds for synthesis. Twenty-two were produced, six performed well in lab tests and one in particular, DN1, proved able to eliminate MRSA skin infections in mice. NG1 and DN1 are structurally distinct from any currently known antibiotics and appear to destroy bacteria by disrupting their cell membranes. NG1 specifically targets LptA, a previously untapped bacterial protein involved in constructing the outer cell membrane. What's next for antibiotic research Phare Bio, a nonprofit in the Antibiotics-AI Project, is refining NG1 and DN1 to improve their drug properties, while researchers expand the AI platform to target other tough pathogens like Mycobacterium tuberculosis (the causative agent of tuberculosis) and Pseudomonas aeruginosa (a group of bacteria that often causes infections in health-care settings). The study, first published in the journal Cell, signals a hopeful turn in the global struggle against superbugs. However, these findings are early-stage. Initial tests and lab results are encouraging, but human safety and efficacy must be established through rigorous lab refinement and clinical trials, a process that could span several years. This effort builds on MIT's previous breakthroughs in AI-guided antibiotic development, including halicin, discovered in 2020 via deep learning, and abaucin, discovered in 2023 via a machine-learning algorithm. Read more: AI Essentials: 29 Ways to Make Gen AI Work for You, According to Our Experts